News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
107,520 Results
Type
Article (4249)
Company Profile (18)
Press Release (103253)
Section
Business (31967)
Career Advice (108)
Deals (5249)
Drug Delivery (5)
Drug Development (5405)
Employer Resources (11)
FDA (3200)
Job Trends (2076)
News (46951)
Policy (3871)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 BioMidwest Digital (3)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
Academia (363)
Allergies (9)
Alliances (11150)
ALS (6)
Alzheimer's disease (301)
Antibody-drug conjugate (ADC) (2)
Approvals (3208)
Artificial intelligence (77)
Automation (3)
Bankruptcy (46)
Best Places to Work (1718)
Biosimilars (6)
Biotechnology (10)
Bladder cancer (7)
Brain cancer (5)
Breast cancer (53)
Cancer (350)
Cardiovascular disease (20)
Career advice (99)
Career pathing (1)
CAR-T (9)
Cell therapy (21)
Cervical cancer (3)
Clinical research (4153)
Collaboration (153)
Compensation (15)
COVID-19 (479)
C-suite (28)
Cystic fibrosis (8)
Data (199)
Decentralized trials (1)
Depression (4)
Diabetes (16)
Diagnostics (5769)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (13)
Drug pricing (3)
Drug shortages (1)
Duchenne muscular dystrophy (4)
Earnings (10392)
Employer branding (2)
Employer resources (11)
Events (13460)
Executive appointments (92)
FDA (3362)
Featured Employer (2)
Fibrodysplasia Ossificans Progressiva (1)
Funding (115)
Gene editing (1)
Generative AI (8)
Gene therapy (13)
GLP-1 (38)
Government (624)
Guidances (4)
Healthcare (2908)
IgA nephropathy (1)
Immunology and inflammation (5)
Indications (1)
Infectious disease (503)
Inflammatory bowel disease (12)
Influenza (9)
Intellectual property (5)
Interviews (12)
IPO (1796)
IRA (1)
Job creations (401)
Job search strategy (94)
Kidney cancer (4)
Labor market (1)
Layoffs (24)
Leadership (1)
Legal (533)
Liver cancer (11)
Lung cancer (40)
Lymphoma (28)
Management (3)
Manufacturing (41)
MASH (6)
Medical device (2449)
Medtech (2449)
Mergers & acquisitions (3526)
Metabolic disorders (34)
Multiple sclerosis (16)
NASH (4)
Neurodegenerative disease (10)
Neuropsychiatric disorders (1)
Neuroscience (350)
NextGen: Class of 2025 (702)
Non-profit (546)
Northern California (303)
Now hiring (2)
Obesity (12)
Opinion (11)
Ovarian cancer (12)
Pain (3)
Pancreatic cancer (8)
Parkinson's disease (13)
Partnered (3)
Patents (17)
Patient recruitment (8)
Peanut (4)
People (8931)
Pharmaceutical (1)
Phase I (1257)
Phase II (1746)
Phase III (1593)
Pipeline (93)
Podcasts (1)
Policy (1)
Postmarket research (212)
Preclinical (589)
Press Release (11)
Prostate cancer (30)
Psychedelics (1)
Radiopharmaceuticals (120)
Rare diseases (28)
Real estate (861)
Recruiting (5)
Regulatory (2997)
Reports (10)
Research institute (425)
Resumes & cover letters (15)
Rett syndrome (1)
Schizophrenia (1)
Series A (14)
Series B (11)
Service/supplier (2)
Sickle cell disease (1)
Southern California (244)
Sponsored (5)
Startups (622)
Stomach cancer (2)
Supply chain (3)
The Weekly (1)
United States (2726)
Vaccines (35)
Venture capitalists (5)
Weight loss (4)
Women's health (5)
Date
Today (18)
Last 7 days (69)
Last 30 days (455)
Last 365 days (5107)
2025 (1057)
2024 (5120)
2023 (6128)
2022 (10210)
2021 (9619)
2020 (8994)
2019 (6146)
2018 (4851)
2017 (5399)
2016 (5389)
2015 (6109)
2014 (4629)
2013 (4126)
2012 (4434)
2011 (4628)
2010 (4078)
Location
Africa (131)
Alabama (6)
Alaska (1)
Arizona (50)
Arkansas (2)
Asia (5310)
Australia (1238)
California (655)
Canada (241)
China (27)
Colorado (47)
Connecticut (58)
Delaware (4)
Europe (15110)
Florida (84)
Georgia (35)
Idaho (4)
Illinois (86)
India (4)
Indiana (27)
Iowa (3)
Japan (19)
Kansas (11)
Kentucky (4)
Louisiana (1)
Maine (20)
Maryland (87)
Massachusetts (362)
Michigan (62)
Minnesota (70)
Missouri (25)
Montana (4)
Nebraska (8)
Nevada (1)
New Hampshire (18)
New Jersey (126)
New Mexico (17)
New York (259)
North Carolina (176)
North Dakota (6)
Northern California (303)
Ohio (23)
Oklahoma (2)
Oregon (6)
Pennsylvania (75)
Rhode Island (3)
South America (153)
South Carolina (2)
Southern California (244)
Tennessee (25)
Texas (151)
Utah (73)
Virginia (34)
Washington D.C. (5)
Washington State (63)
Wisconsin (26)
107,520 Results for "perspectum diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
New Published Data Show Reproducibility and Utility of Perspectum’s MRI in Patients With Metabolic Liver Disease
September 27, 2024
·
3 min read
Press Releases
Perspectum Awarded New FDA Grant to Evaluate Biomarker for Rare Disease Drug Development
November 14, 2024
·
3 min read
Lone Star Bio
Perspectum Completes $19 Million Second Close of Series C Funding Led by Oppenheimer & Co. Inc. (“Oppenheimer”)
Perspectum has completed the second close of its $55 million Series C funding round.
March 15, 2023
·
3 min read
Partnered
Ending the Diagnostic Odyssey for Patients
Ending the diagnostic journey for patients, particularly those with rare diseases, improves patients’ quality of life while reducing costs to healthcare systems.
December 11, 2024
·
4 min read
·
BioSpace Insights
Lone Star Bio
Perspectum Completes $36 Million First Close of Series C Funding Led by Oppenheimer Holdings
Perspectum, a precision health company which develops medical imaging tools to improve the diagnoses of metabolic diseases and cancer, has completed the first close of its Series C funding round.
January 5, 2023
·
3 min read
Press Releases
Newly-formed Archerfish Precision Diagnostics Pte Ltd: Ushers a New Era in Advanced Diagnostics
March 6, 2025
·
5 min read
Business
New Partnership Between Marubeni/Clairvo and Perspectum to Bring LiverMultiScan to Japan
Perspectum announced that it has signed a strategic business partnership with Marubeni Corporation to support entry of Perspectum’s AI diagnostic technology, called LiverMultiScan, into the Japanese market.
May 26, 2021
·
2 min read
Business
Perspectum and HepQuant Announce Partnership to Bring a More Complete Picture of Liver Health
Perspectum and HepQuant are proud to announce a strategic business partnership to provide seamless delivery of HepQuant’s liver function assessment technology via Perspectum’s Contract Research Organization (CRO) services.
November 1, 2021
·
3 min read
Press Releases
Quest Diagnostics to Host Investor Day on March 19, 2025
February 14, 2025
·
1 min read
Press Releases
Avacta Announces Agreement to Sell Launch Diagnostics and a Corporate Update
March 10, 2025
·
6 min read
1 of 10,752
Next
